| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.9B | $13.0B | $11.9B | $12.1B | $12.0B | $11.7B | $11.8B | $12.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.9B | $2.7B | $1.9B | $2.8B | $2.7B | $2.4B | $2.2B | $2.6B |
| EPS (Basic) | $9.55 | $8.33 | $5.65 | $7.28 | $7.30 | $6.40 | $5.43 | $6.48 |
| EPS (Diluted) | $9.40 | $8.21 | $5.58 | $7.19 | $7.19 | $6.32 | $5.38 | $6.40 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $366.0B | $353.2B | $297.3B | $301.4B | $314.6B | $314.7B | $245.6B | $244.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $338.2B | $327.9B | $273.5B | $276.3B | $287.3B | $288.5B | $221.2B | $219.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $27.8B | $25.3B | $23.8B | $25.2B | $27.4B | $26.2B | $24.4B | $24.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $11.9B | $-13.2B | $0.7B | $12.0B | $-6.7B | $3.5B | $5.7B | $10.5B |
| Investing Cash Flow | $-13.0B | $-39.5B | $12.7B | $6.8B | $-2.2B | $-65.5B | $-2.6B | $-4.5B |
| Capital Expenditures | $1.1B | $0.9B | $0.8B | $0.7B | $0.8B | $0.6B | $0.7B | $0.6B |
| Financing Cash Flow | $2.4B | $51.8B | $-13.4B | $-18.4B | $9.0B | $62.2B | $-3.0B | $-4.5B |